Sage Therapeutics CFO and GC depart as part of workforce reorganization; separation agreements signed

Sage Therapeutics, Inc.

CFO Kimi Iguchi and GC Anne Marie Cook resigned on Oct 31, 2024, as part of a previously announced workforce reorganization.
Iguchi receives 12-month salary continuation, COBRA, and a prorated 50% bonus; also enters consulting agreement through Mar 31, 2025, with hourly pay.
Cook receives similar severance (12-month salary continuation, COBRA, prorated 50% bonus); no consulting agreement.
Equity awards amended: for Iguchi, vesting continues during consulting and exercise extended to Oct 31, 2025; for Cook, exercise extended to same date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Anne Marie Cook

Senior Vice President, General Counsel and Secretary

Sage Therapeutics, Inc.

Effective: 2024-10-31
Filed: November 1, 2024, 7:59 PM ET

On the Separation Date, Anne Marie Cook and the Company entered into a separation agreement (the “Cook Separation Agreement”) providing for the resignation of Ms. Cook from her positions as Senior Vice President, General Counsel and Secretary of the Company

Departed

Kimi Iguchi

Chief Financial Officer and Treasurer

Sage Therapeutics, Inc.

Effective: 2024-10-31
Filed: November 1, 2024, 7:59 PM ET

On October 31, 2024 (the “Separation Date”), Kimi Iguchi and Sage Therapeutics, Inc. (the “Company”) entered into a separation agreement (the “Iguchi Separation Agreement”) providing for the resignation of Ms. Iguchi from her positions as the Chief Financial Officer and Treasurer of the Company

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Anne Marie Cook resigned as Senior Vice President, General Counsel and Secretary at Sage Therapeutics, Inc..

Action: resigned
Role: Senior Vice President, General Counsel and Secretary

Exact text from the filing

On the Separation Date, Anne Marie Cook and the Company entered into a separation agreement (the “Cook Separation Agreement”) providing for the resignation of Ms. Cook from her positions as Senior Vice President, General Counsel and Secretary of the Company

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kimi Iguchi resigned as Chief Financial Officer and Treasurer at Sage Therapeutics, Inc..

Action: resigned
Role: Chief Financial Officer and Treasurer

Exact text from the filing

On October 31, 2024 (the “Separation Date”), Kimi Iguchi and Sage Therapeutics, Inc. (the “Company”) entered into a separation agreement (the “Iguchi Separation Agreement”) providing for the resignation of Ms. Iguchi from her positions as the Chief Financial Officer and Treasurer of the Company

View on SEC.gov

Source: SEC EDGAR

accession 0001193125-24-249830

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.